FindTrial
Sign In

A study to check plasma (the colourless liquid part of blood, in which the blood cells, etc. float) quality drawn from blood using Blood Plasma Separation device which is intended for liquid biopsy application

â??A pilot study to assess quality of plasma extracted using Blood Plasma Separation Micro-device for Liquid Biopsy applicationâ??. - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/07/044402
Enrollment
25
Registered
2022-07-27
Start date
Unknown
Completion date
Unknown
Last updated
2022-08-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C509- Malignant neoplasm of breast of unspecified site

Interventions

Intervention1: Not applicable: Not applicable

Sponsors

Dassault Systemes Foundation India
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Signed Informed Consent Form. 2. Women or men aged >=18 years and having metastatic breast cancer.

Exclusion criteria

Exclusion criteria: 1. Poor peripheral venous access. 2. Terminally ill patients. 3. Patient with bleeding diathesis. 4. Patients on anticoagulation medication. 5. Patients tested positive for human immunodeficiency (HIV), Active hepatitis B or hepatitis Cvirus. 6. Any other serious medical condition or abnormality that, in the investigatorâ??s discrement, hinders patientâ??s safety.

Design outcomes

Primary

MeasureTime frame
1. To evaluate the concentration of cfDNA obtained from the plasma extracted by micro-device. 2. To compare concentration of cfDNA extracted from the plasma by the micro-device vs the standard technique of centrifugation.Timepoint: 20 minutes—

Secondary

MeasureTime frame
NATimepoint: NA—

Countries

India

Contacts

Public ContactYogesh Kembhavi

ACTREC

spatwardhan@actrec.gov.in02227405711

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026